RadNet, Inc. (RDNT)
76.42
+0.38
(+0.50%)
USD |
NASDAQ |
Nov 13, 16:00
76.41
-0.01
(-0.01%)
After-Hours: 19:59
RadNet EPS Diluted (Quarterly) : 0.0524 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0524 |
| June 30, 2026 | 0.0956 |
| March 31, 2026 | -0.4343 |
| December 31, 2025 | -0.0078 |
| September 30, 2025 | 0.07 |
| June 30, 2025 | 0.1914 |
| March 31, 2025 | -0.5099 |
| December 31, 2024 | 0.0708 |
| September 30, 2024 | 0.0427 |
| June 30, 2024 | -0.0406 |
| March 31, 2024 | -0.0401 |
| December 31, 2023 | -0.0274 |
| September 30, 2023 | 0.2549 |
| June 30, 2023 | 0.1374 |
| March 31, 2023 | -0.364 |
| December 31, 2022 | -0.0164 |
| September 30, 2022 | 0.0116 |
| June 30, 2022 | 0.1388 |
| March 31, 2022 | 0.0535 |
| December 31, 2021 | -0.0721 |
| September 30, 2021 | 0.3014 |
| June 30, 2021 | 0.0541 |
| March 31, 2021 | 0.179 |
| December 31, 2020 | 0.114 |
| September 30, 2020 | 0.1185 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.2091 |
| March 31, 2020 | -0.3252 |
| December 31, 2019 | 0.2053 |
| September 30, 2019 | 0.0634 |
| June 30, 2019 | 0.0977 |
| March 31, 2019 | -0.0753 |
| December 31, 2018 | 0.5915 |
| September 30, 2018 | 0.1036 |
| June 30, 2018 | 0.11 |
| March 31, 2018 | -0.15 |
| December 31, 2017 | -0.15 |
| September 30, 2017 | 0.07 |
| June 30, 2017 | 0.11 |
| March 31, 2017 | -0.03 |
| December 31, 2016 | 0.08 |
| September 30, 2016 | 0.04 |
| June 30, 2016 | 0.08 |
| March 31, 2016 | -0.03 |
| December 31, 2015 | 0.02 |
| September 30, 2015 | 0.18 |
| June 30, 2015 | 0.08 |
| March 31, 2015 | -0.11 |
| December 31, 2014 | 0.10 |
| September 30, 2014 | 0.10 |
| June 30, 2014 | 0.12 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Castle Biosciences, Inc. | -0.1338 |
| Lumexa Imaging Holdings, Inc. | 0.0746 |
| Quest Diagnostics, Inc. | 2.768 |
| Labcorp Holdings, Inc. | 3.221 |
| OPKO Health, Inc. | -0.0717 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.15M |
| Revenue (Quarterly) | 638.26M |
| Total Expenses (Quarterly) | 634.10M |
| Enterprise Value | 7.758B |
| Gross Profit Margin (Quarterly) | 6.51% |
| Profit Margin (Quarterly) | 3.00% |
| Earnings Yield | -0.38% |
| Operating Earnings Yield | 1.88% |
| Normalized Earnings Yield | 0.0522 |